Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

736

Participants

Timeline

Start Date

February 13, 2005

Primary Completion Date

February 27, 2009

Study Completion Date

December 31, 2025

Conditions
Breast Cancer
Interventions
DRUG

Fulvestrant

intramuscular injection

Trial Locations (106)

1010

Research Site, Caracas

1053

Research Site, Caracas

1060

Research Site, Caracas

1070

Research Site, Brussels

1090

Research Site, Brussels

2300

Research Site, Turnhout

2417

Research Site, Trivandrum

2650

Research Site, Edegem

2930

Research Site, Brasschaat

3500

Research Site, Hasselt

4000

Research Site, Liège

4400

Research Site, Nyíregyháza

8000

Research Site, Székesfehérvár

9000

Research Site, Ghent

9700

Research Site, Szombathely

14140

Research Site, México

15006

Research Site, A Coruña

16132

Research Site, Genova

18009

Research Site, Cherkasy

21100

Research Site, Varese

21237

Research Site, Rosedale

24128

Research Site, Bergamo

27858

Research Site, Greenville

28040

Research Site, Madrid

29010

Research Site, Málaga

33011

Research Site, Oviedo

33081

Research Site, Aviano

33308

Research Site, Fort Lauderdale

34429

Research Site, Crystal River

37007

Research Site, Salamanca

40022

Research Site, Sumy

41012

Research Site, Carpi

41013

Research Site, Seville

42100

Research Site, Reggio Emilia

46023

Research Site, Ternopil

48202

Research Site, Detroit

49102

Research Site, Dnipro

53095

Research Site, West Bend

59100

Research Site, Prato

59401

Research Site, Moscow

61801

Research Site, Urbana

63141

Research Site, St Louis

64131

Research Site, Kansas City

77504

Research Site, Pasadena

79031

Research Site, Lviv

83092

Research Site, Donetsk

85122

Research Site, Casa Grande

88000

Research Site, Uzhhorod

92708

Research Site, Fountain Valley

107005

Research Site, Moscow

115478

Research Site, Moscow

121356

Research Site, Moscow

150054

Research Site, Yaroslavl

153040

Research Site, Ivanovo

191014

Research Site, Saint Petersburg

197089

Research Site, Saint Petersburg

197758

Research Site, Saint Petersburg

249020

Research Site, Obninsk

302004

Research Site, Marg Jaipur

302013

Research Site, Jaipur

350040

Research Site, Krasnodar

390046

Research Site, Ryazan

398005

Research Site, Lipetsk

400012

Research Site, Mumbai

411001

Research Site, Pune

420029

Research Site, Kazan, Tatarstan

420111

Research Site, Kazan, Tatarstan

462001

Research Site, Bhopal

500082

Research Site, Hyderabad

603081

Research Site, Nizhny Novgorod

632004

Research Site, Vellore

700054

Research Site, Kolkata

1240000

Research Site, Antofagasta

8380455

Research Site, Santiago

06052

Research Site, New Britain

08043

Research Site, Voorhees Township

14784-400

Research Site, Barretos

86010-640

Research Site, Londrina

91350-200

Research Site, Porto Alegre

50670-420

Research Site, Recife

40170-070

Research Site, Salvador

04039-001

Research Site, São Paulo

Unknown

Research Site, Santiago

Research Site, Bogotá

Research Site, Santiago de Cali

656 53

Research Site, Brno

370 87

Research Site, České Budějovice

520 03

Research Site, Pardubice

100 34

Research Site, Prague

128 08

Research Site, Prague

180 00

Research Site, Prague

390 03

Research Site, Tábor

150 06

Research Site, V Uvalu 84

110 029

Research Site, Ansārinagar

576 104

Research Site, Manipal

VLT 14

Research Site, Floriana

06720

Research Site, Mexico City

01090

Research Site, México

15-027

Research Site, Bialystok

90-553

Research Site, Lodz

61-878

Research Site, Poznan

08501

Research Site, Bardejov

812 50

Research Site, Bratislava

949 01

Research Site, Nitra

917 75

Research Site, Trnava

03022

Research Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY